.svg){kind=small}
Jul-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
Kikoko is stocked at 251 licensed dispensaries across California, with the deepest coverage in Los Angeles, San Francisco, Fresno, Sacramento, and San Diego. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In July 2026, Capsules held 81.5% share with a year-over-year decline of 47.2% and a month-over-month drop of 10.2%, while Edible accounted for 14.0% share with a 27.9% YoY decline and a 13.5% MoM decrease; Beverage represented 4.5% share with a 10.3% YoY decline and a 13.2% MoM decrease. Overall brand sales were down 44.1% YoY and 64.4% versus 24 months prior, alongside a 2.9% YoY reduction in average price to $35.36. The concentration in Capsules coupled with faster YoY contraction than Edible and Beverage implies overexposure to a weakening core segment, suggesting the current mix is amplifying Kikoko’s headline declines.
Capsules rank 6 in California, yet the category’s 10.2% MoM and 47.2% YoY drops indicate share defense requires more than price moves given only a 2.9% YoY price decrease at the brand level. Edible’s smaller 27.9% YoY decline versus Capsules’ 47.2%, and Beverage’s milder 10.3% YoY decline despite 13.2% MoM pressure, imply reallocating toward faster-holding subcategories could stabilize performance while protecting positioning in Capsules through targeted assortment rather than volume-heavy pushes. The pattern points to a positioning pivot: maintain presence in rank-anchoring Capsules while shifting mix toward Edible and Beverage to reduce exposure risk and smooth volatility across months.
Competitive Landscape
Kikoko ranks #6 in CA Capsules in July 2026, down 2 positions year over year from #4, and flat versus April 2026 at #6; meanwhile, category leader Breez sits at #1 after a year-over-year decline in sales of 32.37%, and Emerald Bay Extracts advanced from #5 to #2 with 40.61% sales growth, indicating competitive share is rotating upward toward faster-growing rivals while Kikoko holds a mid-pack spot. Kikoko’s peak at #4 in December 2025 contrasts with a three-month hold at #6 through May 2026 and July 2026, while Buddies moved up from #6 to #5 with 29.21% sales growth and Level slid from #1 to #4 with a 60.24% sales drop, implying Kikoko’s rank trajectory points to stagnation risk unless it captures share from declining leaders or matches the growth cadence of climbing competitors.
Notable Products
XTabs - Indica High Dose Tablets 20-Pack (1000mg) posted the steepest decline at -21.2% MoM while slipping to rank 3, whereas XTabs - Sativa High Dose Tablets 20-Pack (1000mg) fell -9.3% MoM but held rank 1. XTabs - Hybrid High Dose Tablets 20-Pack (1000mg) in rank 2 eked out +1.3% MoM, creating a split where two of the top three moved down while one inched up. With four of the top five positions held by Capsules SKUs and aggregate Capsule leadership anchored at ranks 1–3, the pattern implies dependence on high-dose tablets even as volatility within that set increases.
Little Helpers - CBN/THC/Melatonin 3:2 Sleep Mints 20-Pack (60mg CBN, 40mg THC, 20mg Melatonin) slid -9.2% MoM at rank 4, while Little Helpers - CBD/THC 2:1 Calm Mints 20-Pack (100mg CBD, 50mg THC) dropped -22.8% MoM at rank 6. In contrast, Little Helpers - Buzz Mints 20-Pack (100mg) grew +3.6% MoM at rank 7, and the THC/THCV Boost Matcha Mints nudged -0.5% MoM at rank 8, signaling mixed traction across Edibles. With Edibles occupying ranks 4, 6, 7, and 8 but below the Capsules trio in both rank and month-over-month momentum, the mix points to Kikoko prioritizing tablet-led potency while treating mints as secondary trial-priced traffic drivers around $87,656 in flagship tablet sales.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
